NASDAQ:TARS

Tarsus Pharmaceuticals Stock Predictions

etoro logo Buy TARS
*Your capital is at risk
$58.76
+1.35 (+2.35%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TARS Prediction Chart

TARS Predictions History

Latest community submissions for TARS.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 1, 2025 $58.61 -1.38% $57.34 V 97.79% 1
Oct 1, 2025 $58.92 -0.86% $57.34 V 97.25% 1
Oct 1, 2025 $63.00 +6.01% $57.34 X 90.13% 0
Jan 3, 2025 $54.12 -1.86% $55.67 X 97.22% 0
Jan 3, 2025 $54.51 -1.16% $55.67 X 97.91% 0
Skagitqg Skagitqg Merchant
Jan 3, 2025 Bullish $55.67 V 1
Aug 1, 2023 $21.34 -3.05% $18.27 V 83.20% 1
Aug 1, 2023 $22.43 +1.90% $18.27 X 77.24% 0
JS JS Pro
Aug 1, 2023 $21.74 -1.23% $18.27 V 81.01% 1
Jul 31, 2023 $22.24 -2.92% $22.01 V 98.95% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TARS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TARSUS PHARMACEUTICALS, INC.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE